News - MedTech & Diagnostics
RACS and GESA sign agreement to enhance colonoscopy services

MedTech News: The Gastroenterological Society of Australia (GESA) and the Royal Australasian College of Surgeons (RACS) announced they have signed a Memorandum of Understanding (MoU) in relation to RACS’ involvement in the GESA Recertification in Colonoscopy Program (RCP).
The MoU outlines a commitment from both parties to formalise the representation of RACS on the RCP Committee and to contribute to the determination of standards for colonoscopy recertification. The RCP was established by GESA in 2016.
GESA Vice-President Professor Benedict Devereaux and RACS Councillor Professor Andrew Hill said that the MoU was an important development in ensuring all Australians have access to colonoscopy services that are performed to the highest standard.
“The RCP is an important program that sets critical benchmarks for the delivery of colonoscopy services. The MoU indicates a commitment to ways in which we can work together for endoscopists to improve the delivery of high-quality colonoscopy services across Australia.”
“GESA and RACS have a shared interest in ensuring that we deliver the best possible outcomes to our patients, and that is what is at the heart of this agreement. Our focus is on providing Australians with the certainty that they are undergoing colonoscopies performed by high quality, certified endoscopists whether they reside in metropolitan or regional centres.”
Members of the GESA Recertification in Colonoscopy Program (RCP) Committee are as follows:
- Dr Mark Schoeman- Committee Chairman & Gastroenterologist
- Dr Melissa Jennings- Gastroenterologist
- A/Prof Peter Katelaris- Gastroenterologist
- Mr Brian Kirkby- General Surgeon
- Dr David Scott- Gastroenterologist
- Mr Iain Skinner- Colorectal Surgeon
Digital & Innovation
Health sector faces new privacy obligations
Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]
MoreNews - Pharmaceuticals
TGA approves new antibiotic but AMR blind spot remains a critical concern
The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]
MoreNews - MedTech & Diagnostics
BCAL Diagnostics rejects merger speculation
ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]
MoreNews - Pharmaceuticals
Australia backs infectious disease innovation as US funding faces more cuts
Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]
More